Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-23-093906
Filing Date
2023-08-21
Accepted
2023-08-21 16:05:25
Documents
2
Period of Report
2023-08-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2324209-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2324209-1_3seq1.xml 3 1629
2 EXHIBIT 24 tm2324209d1_ex24.htm EX-24 6676
  Complete submission text file 0001104659-23-093906.txt   9824
Mailing Address 400 SOMERSET CORPORATE BOULEVARD BRIDGEWATER NJ 08807
Business Address
McKenna Mark C. (Reporting) CIK: 0001749623 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41740 | Film No.: 231189151

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

EIN.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)